General Anesthesia or Combined Spinal-epidural Anesthesia With Ketofol Sedation in Colon Cancer Surgery?
1 other identifier
observational
60
0 countries
N/A
Brief Summary
Anesthesia management in colon cancer surgery affects the postoperative mobilization, discharge and oral intake times of the patients. Due to the side effects of opioids, their use is tried to be reduced and therefore regional anesthesia methods are preferred in suitable patients. Especially in the preoperative period, opioid use has a negative effect on the recovery processes, morbidity and mortality of the patients. Epidural analgesia, a central block method, is recommended for postoperative pain control in ERAS protocols. Opioids suppress cellular and humoral immunity. Epidural analgesia reduces both opioid consumption and surgical stress response. It has been shown that epidural analgesia maintains the immune functions of patients and is associated with a decrease in tumor recurrence. It has also been shown to reduce postoperative pain, hypercoagulability and pulmonary complications, increase exercise capacity and accelerate the return of intestinal functions to normal. In line with this information, in this study, it was aimed to investigate the differences in the postoperative period in patients managed with regional anesthesia. In the study, it was planned to create two groups who underwent open surgery for colon cancer. The first group will be operated under general anesthesia and the second group will be operated under combined spinal-epidural anesthesia with ketofol sedation. An epidural catheter will be inserted in both groups for postoperative pain management. In the study, patients' age, gender, weight, comorbidity, ASA score, amount of local anesthetic used, postoperative VAS scores, mobilization time, time to start oral intake, nasogastric withdrawal time, drain removal time, urinary catheter withdrawal time, hospitalization time and total cost will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedApril 19, 2022
April 1, 2022
11 months
November 19, 2021
April 12, 2022
Conditions
Outcome Measures
Primary Outcomes (19)
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative 2nd hour.
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative 4th hour.
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative 8th hour.
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative 12th hour.
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative16th hour.
visual analog scale (VAS)
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
postoperative 24th hour.
time to start oral intake
the time the patient start to consume orally after the operation
to be observed until the start of oral intake after the operation. it will be assessed up to 720 hours.
mobilization time
the time the patient was start to walk after the operation
to be observed until the start of walking after the operation. it will be assessed up to 720 hours.
urinary catheter withdrawal time
the time the urinary catheter was withdrawn after the operation
to be observed until the withdrawal of urinary catheter after the operation. it will be assessed up to 720 hours.
hospitalization time
The time from the day the patient was hospitalized before the operation to the day of discharge after the operation.
from hospitalization for the operation to the day of discharge, it will be assessed up to 30 days.
nasogastric withdrawal time
the time the nasogastric tube was withdrawn after the operation.
to be observed until the withdrawal of nasogastric tube after the operation. it will be assessed up to 720 hours.
drain removal time
the time the abdominal drain was withdrawn after the operation.
to be observed until the withdrawal of abdominal drain after the operation. it will be assessed up to 720 hours.
complications
all complications related with surgery or anesthesia
to be observed for 30 days postoperatively.
blood pressure
patients' mean arterial pressure levels
preoperatively
blood pressure
patients' mean arterial pressure levels
perioperatively. "30 minutes" will be taken as the measurement period.
FiCO2
inspiratory carbondioxide level
preoperatively
FiCO2
inspiratory carbondioxide level
perioperatively. "30 minutes" will be taken as the measurement period.
sPO2
oxygene saturation
preoperatively
sPO2
oxygene saturation
perioperatively. "30 minutes" will be taken as the measurement period.
Study Arms (2)
general anesthesia group
Patients in this group will undergo open colon cancer surgery under general anesthesia. Epidural catheterization will be applied for postoperative analgesia.
combined spinal-epidural anesthesia group
Patients in this group will undergo open colon cancer surgery under combined spinal-epidural anesthesia with ketofol sedation. Epidural catheterization will be applied for postoperative analgesia.
Interventions
Combined spinal and epidural anaesthesia is a regional anaesthetic technique, which combines the benefits of both spinal anaesthesia and epidural anaesthesia and analgesia. The spinal component gives a rapid onset of a predictable block. The indwelling epidural catheter gives the ability to provide long lasting analgesia and to titrate the dose given to the desired effect.
Eligibility Criteria
Patients over 40 years of age who are scheduled for open surgery with a diagnosis of colon cancer.
You may qualify if:
- Patients over 40 years of age who are scheduled for open surgery with a diagnosis of colon cancer
You may not qualify if:
- Local anesthetic allergy
- Patients scheduled for laparoscopic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Wu HL, Tai YH, Mandell MS, Tsou MY, Yang SH, Chen TH, Chang KY. Effect of epidural analgesia on cancer prognosis after colon cancer resection: a single-centre cohort study in Taiwan. BMJ Open. 2020 Oct 22;10(10):e036577. doi: 10.1136/bmjopen-2019-036577.
PMID: 33093029BACKGROUNDCummings KC III, Zimmerman NM, Maheshwari K, Cooper GS, Cummings LC. Epidural compared with non-epidural analgesia and cardiopulmonary complications after colectomy: A retrospective cohort study of 20,880 patients using a national quality database. J Clin Anesth. 2018 Jun;47:12-18. doi: 10.1016/j.jclinane.2018.03.005. Epub 2018 Mar 12.
PMID: 29544203BACKGROUNDLjungqvist O, Hubner M. Enhanced recovery after surgery-ERAS-principles, practice and feasibility in the elderly. Aging Clin Exp Res. 2018 Mar;30(3):249-252. doi: 10.1007/s40520-018-0905-1. Epub 2018 Feb 16.
PMID: 29453605BACKGROUNDGustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, Rockall TA, Young-Fadok TM, Hill AG, Soop M, de Boer HD, Urman RD, Chang GJ, Fichera A, Kessler H, Grass F, Whang EE, Fawcett WJ, Carli F, Lobo DN, Rollins KE, Balfour A, Baldini G, Riedel B, Ljungqvist O. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS(R)) Society Recommendations: 2018. World J Surg. 2019 Mar;43(3):659-695. doi: 10.1007/s00268-018-4844-y.
PMID: 30426190BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, MD
Study Record Dates
First Submitted
November 19, 2021
First Posted
April 19, 2022
Study Start
April 1, 2022
Primary Completion
March 1, 2023
Study Completion
April 1, 2023
Last Updated
April 19, 2022
Record last verified: 2022-04